Facilitated By

San Antonio Medical Foundation

A PHASE 2B, PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-BLIND, MULTI-CENTER STUDY OF GCS-100 IN PATIENTS WITH CHRONIC KIDNEY DISEASE CAUSED BY DIABETES

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Bansal,Shweta
Funded by
LA JOLLA PHARMACEUTICAL COMPANY
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Diabetes and Obesity